SHORT ANSWERS FROM STUDIES AND THE FDA LABEL
PT-141 FAQ
The name PT-141 refers to bremelanotide, a drug that begins with the brain. This page answers common questions about use, harm, amount, and timing.
What is PT-141, and where does it act?
The name PT-141 means bremelanotide, which joins seven protein parts into a lab-made ring. The drug acts in the brain to affect desire and physical readiness [1].
Only one use has FDA approval. It treats a later loss of desire that lasts, begins before menopause, and causes real upset [7].
What is the PT-141 peptide made from?
Peptides are brief chains made from protein building blocks. This one has seven blocks in a ring and is based on a body-made hormone [1][8].
Joined ends keep your body from breaking the drug down too fast [6]. For you, the ring matters more than the lab spelling of each block [6].
What did the PT-141 peptide change in women?
The drug acts in brain regions involved in forming sexual desire [1]. Its main action doesn't increase blood flow through your body.
In two Phase 3 studies, the last major trials, treated women reported that desire rose and distress fell [3]. All had ongoing low desire and had not gone through menopause.
What does the FDA approve PT-141 to treat?
Bremelanotide is approved only when a woman once had normal desire and later lost it. The problem must last, cause distress, and occur across partners and settings [7].
Use in men, for erection trouble, or after menopause isn't approved. Studies of those uses remain early and don't share the FDA approval [1][9].
Do PT-141 and bremelanotide mean the same drug?
Yes. The label uses bremelanotide, while study papers may use PT-141 [7].
The names point to one drug with a single chemical makeup [6]. Your doctor may use either name.
Why does the label use the name bremelanotide?
On the FDA label, bremelanotide is the name for PT-141. In June 2019, approval covered some women whose ongoing low desire brought distress [6][7].
When needed, the label lists a 1.75 mg shot beneath the skin. That reports the label; it does not select an amount for you.
How much benefit did PT-141 show in large trials?
In Phase 3, the last major trials, the drug group's average desire gain beat placebo by 0.35 points [3]. Distress improved 0.33 points, based on question 13 about how bothered each woman felt.
Those gaps were small on average. Later reviews also judged the effects to be modest [10].
How does PT-141 affect desire in the brain?
The drug acts at brain sites that help create sexual desire [1][3]. Those sites may release dopamine, a brain chemical involved in wanting.
It doesn't act mainly on blood vessels [1]. Its first known effect is in your brain.
What the numbered cell switches mean for PT-141
The drug acts more on switch 4 than switch 3 [1]. The numbers are lab names, not scores or amounts.
These switches help govern desire, hunger, and skin color [8]. Their wide role helps explain why one drug can have such different effects.
Does PT-141 act on desire or blood flow?
PT-141 acts first in the brain. PDE-5 drugs are pills that open vessels so the penis receives more blood [1].
In women, desire rose and brain regions formed stronger links during sexual pictures [5]. That backs an effect led by the brain.
What cell switches does the drug turn on?
The drug turns on a family of cell switches used by hormones made in your body [8]. These switches help carry messages between cells.
PT-141 acts mainly on two of these switches in the brain [1]. They help govern your desire and hunger.
Does PT-141 raise the hormone testosterone?
No. PT-141 doesn't directly raise testosterone or act through the glands that control that hormone [1].
The drug changes desire through switches in the brain. More sexual interest doesn't mean testosterone rose.
How do PT-141 and PDE-5 blood-flow drugs differ?
PDE-5 drugs widen blood vessels, raising blood flow into the penis. PT-141 instead acts where the brain helps create desire [1].
One kind alters blood flow. The other begins with your sexual interest in the brain.
What is the PT-141 dosage stated by the label?
Within the approved use, the label gives a 1.75 mg shot placed below the skin as needed. It permits one dose in 24 hours and no more than 8 doses monthly [6].
Those figures state the label and don't direct your care. Your doctor must decide whether the drug suits your health.
Can this page choose a PT-141 amount for me?
No. This page only reports the label's 1.75 mg shot placed below the skin as needed [6].
The approval applies to one defined type of low desire before menopause. Your doctor would weigh any choice against your health record.
Which PT-141 amounts did the studies compare?
Phase 3, the final large trials, used a 1.75 mg shot when needed [3][6]. Before that, Phase 2 compared 0.75 mg, 1.25 mg, and 1.75 mg [3].
These amounts describe the studies. They aren't directions for you to inject anything.
Does approved PT-141 require mixing?
No. The approved medicine is a prefilled, single-dose shot placed below the skin, not a powder [6].
A vial marked "PT-141 research chemical" does not match the approved product. We don't give human-use mixing directions for that powder [6].
How does the label say approved PT-141 is given?
The approved drug is a shot beneath your skin. The label says it is given at least 45 minutes before sex [6].
An earlier nasal spray sent an uneven amount into the blood, so researchers dropped it [6]. These are label facts, not personal directions.
What repeat-use limits appear on the PT-141 label?
The label limits the drug to one dose in 24 hours and no more than 8 doses each month [6]. Those figures state the approved label.
They aren't personal advice. Any choice needs a doctor's review of your health.
What amount does the bremelanotide label list for one shot?
For women with a defined low-desire problem, the label gives a 1.75 mg shot below the skin as needed [6]. It permits one dose in 24 hours and no more than 8 doses monthly.
These details state the label. They don't choose an amount for you.
What is the PT-141 dosage for women before menopause?
Among those covered by approval, the label gives a 1.75 mg shot below the skin when needed. It says at least 45 minutes before sex [6].
A person is limited to one dose in 24 hours and no more than 8 doses monthly. These label figures don't plan your care.
How long does PT-141 last in blood and in felt desire?
Doctors use half-life for the time a blood amount takes to drop by half. After a shot, that was about 2.7 hours, spanning 1.9-4.0 hours, with a peak around 0.5-1.0 hours [6].
One brain-scan study found more sexual desire for up to 24 hours [5]. How long the drug stays in blood differs from how long you may feel it.